76 related articles for article (PubMed ID: 9126321)
21. Immunohistochemical and two-parameter flow cytometric studies of DNA topoisomerase II alpha in human epithelial ovarian carcinoma and germ cell tumor.
Tanoguchi K; Sasano H; Yabuki N; Kikuchi A; Ito K; Sato S; Yajima A
Mod Pathol; 1998 Feb; 11(2):186-93. PubMed ID: 9504690
[TBL] [Abstract][Full Text] [Related]
22. Expression of DNA topoisomerase I and DNA topoisomerase II-alpha in carcinoma of the colon.
Staley BE; Samowitz WS; Bronstein IB; Holden JA
Mod Pathol; 1999 Apr; 12(4):356-61. PubMed ID: 10229499
[TBL] [Abstract][Full Text] [Related]
23. Adenovirus-mediated human topoisomerase IIalpha gene transfer increases the sensitivity of etoposide-resistant human breast cancer cells.
Zhou Z; Zwelling LA; Kawakami Y; An T; Kobayashi K; Herzog C; Kleinerman ES
Cancer Res; 1999 Sep; 59(18):4618-24. PubMed ID: 10493516
[TBL] [Abstract][Full Text] [Related]
24. DNA topoisomerase IIalpha and -beta expression in human ovarian cancer.
Withoff S; van der Zee AG; de Jong S; Hollema H; Smit EF; Mulder NH; de Vries EG
Br J Cancer; 1999 Feb; 79(5-6):748-53. PubMed ID: 10070864
[TBL] [Abstract][Full Text] [Related]
25. Transfection of 9-hydroxyellipticine-resistant Chinese hamster fibroblasts with human topoisomerase IIalpha cDNA: selective restoration of the sensitivity to DNA religation inhibitors.
Khélifa T; René B; Le Mée S; Lambert B; Saucier JM; Markovits J; Jacquemin-Sablon H; Jacquemin-Sablon A
Cancer Res; 1999 Oct; 59(19):4927-36. PubMed ID: 10519406
[TBL] [Abstract][Full Text] [Related]
26. p53 dependence of topoisomerase I recruitment in vivo.
Mao Y; Okada S; Chang LS; Muller MT
Cancer Res; 2000 Aug; 60(16):4538-43. PubMed ID: 10969804
[TBL] [Abstract][Full Text] [Related]
27. CCAAT binding transcription factor binds and regulates human COL1A1 promoter activity in human dermal fibroblasts: demonstration of increased binding in systemic sclerosis fibroblasts.
Saitta B; Gaidarova S; Cicchillitti L; Jimenez SA
Arthritis Rheum; 2000 Oct; 43(10):2219-29. PubMed ID: 11037881
[TBL] [Abstract][Full Text] [Related]
28. CCAAT binding factor (CBF) binding mediates cell cycle activation of topoisomerase IIalpha. Conventional CBF activation domains are not required.
Hu Q; Bhattacharya C; Maity SN
J Biol Chem; 2002 Oct; 277(40):37191-200. PubMed ID: 12149265
[TBL] [Abstract][Full Text] [Related]
29. Two control elements in the hepatitis B virus S-promoter are important for full promoter activity mediated by CCAAT-binding factor.
Bock CT; Kubicka S; Manns MP; Trautwein C
Hepatology; 1999 Apr; 29(4):1236-47. PubMed ID: 10094970
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical staining for DNA topoisomerase I, DNA topoisomerase II-alpha and p53 in gastric carcinomas.
Coleman LW; Bronstein IB; Holden JA
Anticancer Res; 2001; 21(2A):1167-72. PubMed ID: 11396158
[TBL] [Abstract][Full Text] [Related]
31. Characterization of DNA topoisomerase II alpha/beta heterodimers in HeLa cells.
Gromova I; Biersack H; Jensen S; Nielsen OF; Westergaard O; Andersen AH
Biochemistry; 1998 Nov; 37(47):16645-52. PubMed ID: 9843432
[TBL] [Abstract][Full Text] [Related]
32. Human topoisomerase IIalpha and IIbeta interact with the C-terminal region of p53.
Cowell IG; Okorokov AL; Cutts SA; Padget K; Bell M; Milner J; Austin CA
Exp Cell Res; 2000 Feb; 255(1):86-94. PubMed ID: 10666337
[TBL] [Abstract][Full Text] [Related]
33. Induction of sensitivity to doxorubicin and etoposide by transfection of MCF-7 breast cancer cells with heregulin beta-2.
Harris LN; Yang L; Tang C; Yang D; Lupu R
Clin Cancer Res; 1998 Apr; 4(4):1005-12. PubMed ID: 9563896
[TBL] [Abstract][Full Text] [Related]
34. Human 170 kDa and 180 kDa topoisomerases II bind preferentially to curved and left-handed linear DNA.
Bechert T; Diekmann S; Arndt-Jovin DJ
J Biomol Struct Dyn; 1994 Dec; 12(3):605-23. PubMed ID: 7727061
[TBL] [Abstract][Full Text] [Related]
35. Self-association and DNA binding properties of the human topoisomerase IIA alpha2HTH module.
Morant-Lhomel A; René B; Zargarian L; Troalen F; Mauffret O; Fermandjian S
Biochimie; 2006; 88(3-4):253-63. PubMed ID: 16213649
[TBL] [Abstract][Full Text] [Related]
36. Regulation of the human topoisomerase IIalpha gene promoter in confluence-arrested cells.
Isaacs RJ; Harris AL; Hickson ID
J Biol Chem; 1996 Jul; 271(28):16741-7. PubMed ID: 8663303
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of DNA topoisomerase II alpha gene expression by the p53 tumor suppressor.
Wang Q; Zambetti GP; Suttle DP
Mol Cell Biol; 1997 Jan; 17(1):389-97. PubMed ID: 8972219
[TBL] [Abstract][Full Text] [Related]
38. Role of an inverted CCAAT element in human topoisomerase IIalpha gene expression in ICRF-187-sensitive and -resistant CEM leukemic cells.
Morgan SE; Beck WT
Mol Pharmacol; 2001 Feb; 59(2):203-11. PubMed ID: 11160854
[TBL] [Abstract][Full Text] [Related]
39. Novel C8-linked pyrrolobenzodiazepine (PBD)-heterocycle conjugates that recognize DNA sequences containing an inverted CCAAT box.
Brucoli F; Hawkins RM; James CH; Wells G; Jenkins TC; Ellis T; Hartley JA; Howard PW; Thurston DE
Bioorg Med Chem Lett; 2011 Jun; 21(12):3780-3. PubMed ID: 21570842
[TBL] [Abstract][Full Text] [Related]
40. Reduced level of ATF is correlated with transcriptional repression of DNA topoisomerase II alpha gene during TPA-induced differentiation of HL-60 cells.
Lim K; Lee JI; Yun KA; Son MY; Park JI; Yoon WH; Hwang BD
Biochem Mol Biol Int; 1998 Sep; 46(1):35-42. PubMed ID: 9784837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
